{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:01:30Z","timestamp":1792004490930,"version":"4.4.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.clml.2020.01.012","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T19:25:04Z","timestamp":1580844304000},"page":"e201-e204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Burkitt Lymphoma Presenting as Cranial Multineuritis Secondary to Primary Neurolymphomatosis: A Diagnostic Challenge"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5988-2878","authenticated-orcid":false,"given":"Lindsey","family":"Fitzgerald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.01.012_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1215\/15228517-5-2-104","article-title":"Neurolymphomatosis","volume":"5","author":"Baehring","year":"2003","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.clml.2020.01.012_bib2","doi-asserted-by":"crossref","first-page":"e0303","DOI":"10.1097\/MD.0000000000010303","article-title":"Neurolymphomatosis in non-Hodgkin lymphoma with cranial multineuritis: a case report","volume":"97","author":"Haydaroglu Sahin","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clml.2020.01.012_bib3","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1182\/blood-2009-12-258210","article-title":"Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report","volume":"115","author":"Grisariu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.01.012_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/PPO.0b013e31826c5ad5","article-title":"Diagnosis and management of neurolymphomatosis","volume":"18","author":"Baehring","year":"2012","journal-title":"Cancer J"},{"key":"10.1016\/j.clml.2020.01.012_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3109\/07357900009012197","article-title":"Burkitt\u2019s lymphoma: molecular pathogenesis and treatment","volume":"18","author":"Bishop","year":"2000","journal-title":"Cancer Invest"},{"key":"10.1016\/j.clml.2020.01.012_bib6","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","article-title":"An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt\u2019s lymphoma: results of United Kingdom Lymphoma Group LY06 study","volume":"13","author":"Mead","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2020.01.012_bib7","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1212\/WNL.0b013e318211c379","article-title":"Lennon VA CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG","volume":"76","author":"McKeon","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clml.2020.01.012_bib8","author":"Baehring"},{"key":"10.1016\/j.clml.2020.01.012_bib9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3988\/jcn.2016.12.3.274","article-title":"The diagnostic dilemma of neurolymphomatosis","volume":"12","author":"Shree","year":"2016","journal-title":"J\u00a0Clin Neurol"},{"key":"10.1016\/j.clml.2020.01.012_bib10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/MNM.0b013e3283561881","article-title":"Increasing importance of 18-FDG PET in the diagnosis of neurolymphomatosis","volume":"33","author":"Salm","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.clml.2020.01.012_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s13139-010-0070-8","article-title":"Neurolymphomatosis on F-18 FDG PET\/CT and MRI findings: a case report","volume":"45","author":"Hong","year":"2011","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.clml.2020.01.012_bib12","first-page":"57","article-title":"(18)F-FDG PET\/CT in neurolymphomatosis: report of 3 cases","volume":"2","author":"Canh","year":"2014","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"10.1016\/j.clml.2020.01.012_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/0972-3919.198502","article-title":"18F-FDG PET\/CT\/MRI fusion images showing cranial and peripheral nerve involvement in neurolymphomatosis","volume":"32","author":"Trevisan","year":"2017","journal-title":"Indian J Nucl Med"},{"key":"10.1016\/j.clml.2020.01.012_bib14","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1182\/blood.V128.22.3042.3042","article-title":"Clinical features, diagnosis, and prognosis of 14 cases of neurolymphomatosis: single institutional experience over 10 years","volume":"128","author":"Abe","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.01.012_bib15","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood.V124.21.1717.1717","article-title":"(2014). Clinical features of and treatment outcome of neurolymphomatosis: single institutional experience over 7 years","volume":"124","author":"Fukumoto","year":"2014","journal-title":"Blood"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020300495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020300495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:33:54Z","timestamp":1761870834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020300495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2152265020300495"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.01.012","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burkitt Lymphoma Presenting as Cranial Multineuritis Secondary to Primary Neurolymphomatosis: A Diagnostic Challenge","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}